Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Type-II diabetes mellitus. Patients with HbA1c more than 7%. Patients who receiving oral hypoglycemic and/or insulin therapy. Patients who provide written informed consent. Patients who express willingness to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who are younger than 18 years (They are legally regarded as dependents and consequently they cannot take decisions of their own). Pregnant Women. Patients who will not willing to give consent to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in HbA1C levels in intervention groupTimepoint: Reduction in HbA1C levels exactly after 4 Times in each 4 month intervention during 16 month study period | — |
Secondary
| Measure | Time frame |
|---|---|
| enhancing patients quality of life in the form of reduction of symptoms improving self-management of disease & achieving goal of health promotion & prevention of progression of diabetes mellitusTimepoint: exactly 4 times( each 4 months) Intervention during 16 months study period | — |
Countries
India
Contacts
INDUKAKA IPCOWALA COLLEGE OF PHARMACY